LexDanaLexDanabeta
Inventor

Joel S. Schuman

Inventor
Pittsburgh, PA, US

Overview

21→
Patents
1994–2021
Patent span
Physics
Primary field (CPC G)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Bprimary
A61BDiagnosis19%
A61KPreparations for medical, dental or toiletry purposes13%
G06TImage data processing or generation, in general13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
G01BMeasuring length, thickness or similar linear dimensions10%
G06VImage or video recognition or understanding5%
G16ZInformation and communication technology [ict] specially adapted for specific application fields, not otherwise provided for5%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
G06FElectric digital data processing3%
G06KGraphical data reading3%
PatentTitleYear
10,950,353Systems and methods for disease progression modeling202110,813,549Optical coherence tomography as a rapid, accurate, non-contact method of visualizing the palisades of Vogt202010,575,723Mapping of internal features on en face imagery202010,561,710Goblet cell replacement therapy202010,136,808Optical coherence tomography as a rapid, accurate, non-contact method of visualizing the palisades of Vogt201810,004,766Trabecular meshwork stem cells20189,980,641Optical coherence tomography as a rapid, accurate, non-contact method of visualizing the palisades of Vogt20189,895,419'Goblet cell replacement therapy'20189,872,889Activators of CXCR3 for the treatment of angiopathies of the eye20189,844,315Signal normalization among multiple optical coherence tomography devices20179,514,513'Establishing compatibility between two- and three-dimensional optical coherence tomography scans'20169,452,200'Activators of CXCR3 for the treatment of angiopathies of the eye'20169,180,167'Activators of CXCR3 for the treatment of angiopathies of the eye'20158,911,089'Normalization of retinal nerve fiber layer thickness measurements made by time domain-optical coherence tomography'20148,831,304'Blood vessel segmentation with three-dimensional spectral domain optical coherence tomography'20148,815,946'Inhibition of proliferation and fibrotic response of activated corneal stromal cells'20148,712,505'Automated macular pathology diagnosis in three-dimensional (3D) spectral domain optical coherence tomography (SD-OCT) images'20148,184,885'System and method for visualizing a structure of interest'20127,992,999'Automated assessment of optic nerve head with spectral domain optical coherence tomography'20116,503,892'Method of using matrix metalloproteinase inhibitors in filtering blebs following glaucoma filtering surgery and in the treatment of ischemic damage to the retina and optic nerve'20035,321,501'Method and apparatus for optical imaging with means for controlling the longitudinal range of the sample'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1994–2003Based in Wayland, MA, US· patent location history
2011–2015Patents assigned to UNIV PITTSBURGH (4)· patent assignee history
2011–2021Based in Pittsburgh, PA, US· patent location history
2012–2018Patents assigned to SCHUMAN JOEL S (8)· patent assignee history
2012–2016Patents assigned to ISHIKAWA HIROSHI (5)· patent assignee history
2012–2016Patents assigned to WOLLSTEIN GADI (4)· patent assignee history
2016–2020Patents assigned to UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (10)· patent assignee history
2018Based in New York, NY, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION102016–2020
SCHUMAN JOEL Sself82012–2018
ISHIKAWA HIROSHI52012–2016
UNIV PITTSBURGH42011–2015
WOLLSTEIN GADI42012–2016
Locations
LocationPatentsSpan
Pittsburgh, Pennsylvania, US182011–2021
Wayland, Massachusetts, US21994–2003
New York, New York, US12018